Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia
- Conditions
- Lymphoma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-05-17
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 27
- Registration Number
- NCT00045695
- Locations
- π¨π¦
Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
πΊπΈAbramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania, United States
π¨π¦Margaret and Charles Juravinski Cancer Centre, Hamilton, Ontario, Canada
Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
- Conditions
- Oral ComplicationsHead and Neck Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-04-06
- Lead Sponsor
- NCIC Clinical Trials Group
- Registration Number
- NCT00004234
- Locations
- π¨π¦
British Columbia Cancer Agency, Vancouver, British Columbia, Canada
π¨π¦McGill Cancer Centre, Montreal, Quebec, Canada
π¨π¦Centre Hospitalier Universitaire de Quebec, Quebec City, Quebec, Canada
Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- Radiation: Standard Breast IrradiationRadiation: Breast Radiation plus Regional Radiation
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2023-08-21
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 1832
- Registration Number
- NCT00005957
- Locations
- π¨π¦
CHUQ-Pavillon Hotel-Dieu de Quebec, Quebec City, Quebec, Canada
π¨π¦BCCA - Vancouver Island Cancer Centre, Victoria, British Columbia, Canada
π¨π¦CancerCare Manitoba, Winnipeg, Manitoba, Canada
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen
- Conditions
- Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-04-03
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 211
- Registration Number
- NCT00016380
- Locations
- π¨π¦
Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
π¨π¦Centre Hospitalier Universitaire de Quebec, Quebec City, Quebec, Canada
π¨π¦British Columbia Cancer Agency, Vancouver, British Columbia, Canada
Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma
- Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 332
- Registration Number
- NCT00049673
- Locations
- π¨π¦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
π¨π¦London Regional Cancer Program, London, Ontario, Canada
π¨π¦Cancer Centre of Southeastern Ontario at Kingston, Kingston, Ontario, Canada
Treatment for Chronic Pain in Patients With Advanced Cancer
- Conditions
- LeukemiaLymphomaMyelodysplastic SyndromesPrecancerous/Nonmalignant ConditionUnspecified Adult Solid Tumor, Protocol SpecificPainSmall Intestine CancerChronic Myeloproliferative DisordersMultiple Myeloma and Plasma Cell Neoplasm
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-04-03
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 87
- Registration Number
- NCT00003687
- Locations
- π¨π¦
McGill University, Montreal, Quebec, Canada
π¨π¦Newfoundland Cancer Treatment and Research Foundation, St. Johns, Newfoundland and Labrador, Canada
π¨π¦Princess Margaret Hospital, Toronto, Ontario, Canada